Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-over study of terazosin vs tamsulosin in benign prostatic hyperplasia
KCT0004914Phase 4Not yet recruiting
- Sponsor
- Il-Yang Pharmaceutical
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terazosin, tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Il-Yang Pharmaceutical. Planned start May 2020; status: not yet recruiting.
02
Drugs
terazosintamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on KCT0004914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004914.